NSC |
Compound |
Enrichment |
Correlation |
NSC 621888 |
Cyclopentanone, 2-[(dimethylamino)methyl]-, hydrochloride (9CI) |
0.0185619722391416 |
0.29676753 |
NSC 668261 |
Null |
0.0185619722391416 |
0.097924186 |
NSC 650365 |
Null |
0.0199123109106642 |
0.28184484 |
NSC 694488 |
9H-Quino[4,3,2-de][1,10]phenanthrolin-9-one, 3-(acetoxymethyl)- |
0.0199123109106642 |
0.063729372 |
NSC 750493 |
2-(2-hydroxyphenyl)-3-[5-(1H-imidazol-1-ylmethyl)-1,3,4-oxadiazol-2-yl]-1,3-thiazolidin-4-one |
0.0199123109106645 |
0.2296298 |
NSC 754664 |
3-amino-N-(5-chloro-2-methylphenyl)-5-oxo-5,6,7,8-tetrahydrothieno[2,3-b]quinoline-2-carboxamide |
0.0199123109106645 |
-0.21280174 |
NSC 756363 |
GW804482X |
0.0199123109106645 |
0.032174763 |
NSC 113497 |
16,17-Seco-24-nor-5.alpha.,13.alpha.,14.beta.,17.alpha.-chola-1,20,22-trien-16-oic acid, 14,15.beta.:21,23-diepoxy-7.alpha.,17-dihydroxy-4,4,8-trimethyl-3-oxo-, 16,17-lactone, acetate (8CI) |
0.0209467683758286 |
-0.18582694 |
NSC 129757 |
Null |
0.0209467683758286 |
0.30650137 |
NSC 164991 |
Null |
0.0209467683758286 |
0.11891958 |